文献速递心脑血管急症

杰克逊心脏研究中黑人成人静息心率与新发房颤的关系

Resting Heart Rate and Incident Atrial Fibrillation in Black Adults in the Jackson Heart Study.
PubMed 文献 · JAMA Netw Open · 2024-10-01
一句话结论在黑人成人前瞻性队列中,基线静息心率每升高10次/分,新发房颤风险增加9%(HR 1.09,95%CI 1.00-1.19)。

该研究利用杰克逊心脏研究(密西西比州杰克逊市的前瞻性社区队列)数据,纳入4965名无房颤的黑人成人,随访2000年至2016年,中位随访14年。基线静息心率每升高10次/分,校正房颤危险因素后新发房颤风险增加9%(HR 1.09,95%CI 1.00-1.19);排除基线心力衰竭、心肌梗死及抗心律失常药物使用者的敏感性分析中HR为1.14(95%CI 1.02-1.28)。年龄、性别、体重指数、高血压或体力活动水平未见明显效应修饰。作者认为未来研究应关注静息心率能否用于筛查房颤高危患者。

要点

  • 在4965名黑人成人中,基线静息心率每升高10次/分,校正后新发房颤风险增加9%(HR 1.09,95%CI 1.00-1.19)。
  • 排除基线心力衰竭、心肌梗死及抗心律失常药物使用者后,HR为1.14(95%CI 1.02-1.28)。
  • 中位随访14年期间共发生458例新发房颤,发病率为7.5/1000人年(95%CI 6.8-8.2)。
  • 年龄、性别、体重指数、高血压或体力活动水平未见明显效应修饰。
  • 作者认为未来研究应关注静息心率能否用于筛查房颤高危患者。

适用人群与场景

  • 杰克逊心脏研究中无 prevalent 房颤的黑人成人,纳入分析4965人,平均(SD)年龄55(13)岁,男性1830人(37%)。

研究设计与关键结果

  • 研究类型为前瞻性社区队列(杰克逊心脏研究),纳入4965名无房颤的黑人成人,基线平均(SD)静息心率为65(11)次/分。
  • 中位(IQR)随访14(12-15)年,共发生458例新发房颤,发病率为7.5/1000人年(95%CI 6.8-8.2)。
  • 基线静息心率每升高10次/分,校正房颤危险因素后新发房颤风险增加9%(HR 1.09,95%CI 1.00-1.19)。
  • 敏感性分析排除基线心力衰竭、心肌梗死及抗心律失常药物使用者后,HR为1.14(95%CI 1.02-1.28)。
  • 年龄、性别、体重指数、高血压或体力活动水平未见明显效应修饰。

证据类型、等级与局限

  • 证据类型:前瞻性社区队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为未来研究应关注静息心率能否用于筛查房颤高危患者。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Resting heart rate (RHR) is a widely available measure of cardiovascular fitness that has been associated with several cardiovascular outcomes. RHR has previously been associated with the risk of atrial fibrillation (AF) among individuals of European ancestry, but little is known about this association in Black adults.

OBJECTIVE: To evaluate the association between RHR and incident AF in a large community-based sample of Black adults, independently of established risk factors.

DESIGN, SETTING, AND PARTICIPANTS: This cohort study uses data from the Jackson Heart Study, a prospective community-based cohort in Jackson, Mississippi. Participants without prevalent AF were included and were monitored for new-onset AF during follow-up, from 2000 through 2016. Data analysis was performed from August 1 to December 11, 2023.

EXPOSURE: RHR was assessed from resting 12-lead electrocardiograms performed at examination 1 (2000-2004) and examination 3 (2009-2013).

MAIN OUTCOMES AND MEASURES: AF was identified from study electrocardiograms, hospitalization discharge diagnosis codes, and Medicare claims diagnosis codes. Cox regression was used to evaluate the association between baseline (examination 1) RHR and incident AF, adjusting for established AF risk factors.

RESULTS: Among 4965 Black adults eligible for analysis, the mean (SD) age was 55 (13) years, 1830 (37%) were male, and the mean (SD) RHR at baseline was 65 (11) beats per minute (bpm). During a median (IQR) 14 (12-15) years of follow-up, there were 458 incident AF events, resulting in an incident rate of 7.5 per 1000 person-years (95% CI, 6.8-8.2 incidents per 1000 person-years). Each 10-bpm higher RHR was associated with a 9% higher risk of incident AF after adjustment for AF risk factors (hazard ratio, 1.09; 95% CI, 1.00-1.19). In a sensitivity analysis that excluded individuals with prior heart failure, prior myocardial infarction, and antiarrhythmic medication use at baseline, the hazard ratio was 1.14 (95% CI, 1.02-1.28). There was little evidence of effect modification of these associations by age, sex, body mass index, hypertension, or physical activity level.

CONCLUSIONS AND RELEVANCE: In this large prospective cohort study of Black adults, elevated baseline RHR was associated with increased risk of incident AF, consistent with findings from previous studies of European ancestry populations. Future research should focus on determining whether RHR can be used to screen patients at high risk of AF.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Yogeswaran V, Wiggins KL, Sitlani CM, et al. Resting Heart Rate and Incident Atrial Fibrillation in Black Adults in the Jackson Heart Study. JAMA Netw Open. 2024. PMID: 39476232. doi:10.1001/jamanetworkopen.2024.42319

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。